OrthoPediatrics Corp Payments to Acquire Marketable Securities
OrthoPediatrics Corp (KIDS) reported Payments to Acquire Marketable Securities of $15.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-03-04
- OrthoPediatrics Corp payments to acquire marketable securities for the quarter ending 2025-12-31 was $0.00.
- OrthoPediatrics Corp payments to acquire marketable securities for the quarter ending 2024-12-31 was $0.00.
- OrthoPediatrics Corp payments to acquire marketable securities for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- OrthoPediatrics Corp payments to acquire marketable securities for the quarter ending 2023-09-30 was $4.00M, a 95.30% decline year-over-year.
- OrthoPediatrics Corp payments to acquire marketable securities for fiscal 2025 was $15.00M, a 40.00% decline from fiscal 2024.
- OrthoPediatrics Corp payments to acquire marketable securities for fiscal 2024 was $25.00M, a 48.56% decline from fiscal 2023.
- OrthoPediatrics Corp payments to acquire marketable securities for fiscal 2023 was $48.60M, a 55.87% decline from fiscal 2022.
- OrthoPediatrics Corp payments to acquire marketable securities for fiscal 2022 was $110.12M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $15.00M 10-K · filed 2026-03-04 | ||
| 2025-09-30 | $15.00M 10-Q · filed 2025-10-29 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $25.00M 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $25.00M 10-Q · filed 2025-10-29 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $4.00M derived: sum of 2 quarters · filed 2026-03-04 | $48.60M 10-K · filed 2026-03-04 | |
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $48.60M 10-Q · filed 2023-11-07 | ||
| 2023-06-30 | $44.60M 10-Q · filed 2023-08-01 | |||
| 2022-12-31 | $25.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $110.12M derived: sum of 2 quarters · filed 2025-03-05 | $110.12M 10-K · filed 2025-03-05 | |
| 2022-09-30 | $85.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $85.03M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-01 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 10-K · filed 2024-03-08 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-01 | |||
| 2020-12-31 | $55.00M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |